ThursdayMar 10, 2011 9:04 am

Peregrine Pharmaceuticals, Inc. (PPHM) Appoints New Head of Medical Oncology, Advances Randomized Phase II Trials

Peregrine Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, announced the appointment of Kerstin B. Menander, M.D., Ph.D. as the head of medical oncology. During Dr. Menander’s 30-career, she has led various oncology programs in senior positions at Abbott Laboratories and a variety of other clinical-stage biopharmaceutical companies. She has shown support for 15 approvals in the U.S and Europe, which include Lupron(R), the leading therapy treatment for prostate cancer. At Peregrine, Dr. Menander will be supporting multiple advancing randomized Phase II trial for the company’s main product bavituximab, which is under evaluation in combination with chemotherapy for non-small cell lung…

Continue Reading

ThursdayMar 10, 2011 8:54 am

NIVS IntelliMedia Technology Group (NIV) Earns “AAA” Credit Rating from China Export & Credit Insurance Corp.

Consumer electronics company, NIVS IntelliMedia Technology Group, Inc. announced yesterday that the company earned a “AAA” credit rating from China Export & Credit Insurance Corp. The credit risk rating assessment by Sinosure takes place annually and the “AAA” status is the highest award a company can receive; NIVS has maintained this status for five consecutive years. "We are pleased to announce the continuation of Sinosure's 'AAA' rating for NIVS since 2006," commented Mr. Tianfu Li, Chairman and CEO of NIVS. "This entitlement is a strong recognition of NIVS' risk management and internal control. As we proceed with our planned expansion…

Continue Reading

ThursdayMar 10, 2011 8:52 am

Cavico Corp. (CAVO) Benefits from Vietnamese Developments

Yesterday, Cavico Corp. announced its plans to utilize several infrastructure developments in Vietnam for their benefit. Cavico itself manages large infrastructure projects, such as the construction of hydropower plants, bridges, dams, tunnels, roads, and similar. Developments that are seen as having the possibility to benefit Cavico include the construction of a four-lane tunnel that would link the commercial center of Hanoi to Long Bien District, an increase of infrastructure development loans (reaching $2 billion) to Vietnam by the Asian Development Bank, and an announcement by Nokia to construct a $276 million manufacturing facility in Hanoi. Business Monitor International predicts that…

Continue Reading

ThursdayMar 10, 2011 8:15 am

Descartes Systems Group (DSGX) Posts Strong Performance for Fiscal Q4FY 2011 and FY 2011

Descartes Systems Group, a premier provider of global trade compliance, supply chain execution and mobile resource management services, reported solid fourth-quarter and full-year results for fiscal 2011. "This quarter's and year's financial results were ahead of our internal plans. Our operating performance per diluted share grew more than planned, with a higher ending cash position than originally anticipated. Our strong performance and balance sheet position us well for continued operational excellence and consolidation opportunities," Stephanie Ratza, CFO of Descartes stated in the press release. Revenues were reported at $26.9 million, up 42 percent from $18.9 million reported in the fourth…

Continue Reading

ThursdayMar 10, 2011 8:13 am

Q4 Earnings Review; IncrediMail (MAIL) Posts Record Quarterly Revenues

IncrediMail Ltd., a digital media company that builds downloadable consumer products, yesterday reported record fourth-quarter results, as well as record 2010 revenue. Revenues in 2010 were a record $29.5 million, increasing 8.5 percent, over revenues reported in 2009; adjusted EBITDA in 2010 was $13.4 million, compared to $12.9 million in 2009, reflecting 46 percent of revenues; net income for 2010 was $8.4 million, or $0.85 per diluted share; and cash flow from operations in 2010 was $9.8 million. Josef Mandelbaum, IncrediMail's CEO, said the company’s deal with Google in the second half of 2010, as well as several other achievements,…

Continue Reading

ThursdayMar 10, 2011 8:12 am

Comverge Inc. (COMV) Posts Q4 Results, Recognizes Significant Achievements

Comverge Inc., the leading provider of Intelligent Energy Management (IEM) solutions, yesterday announced fourth quarter and full year 2010 financial and operating results, highlighting record annual revenues, increased megawatts and new contracts. Fourth-quarter revenues for 2010 decreased 9 percent to $37.2 million compared to $40.8 million in the fourth quarter of 2009. Full-year revenues were $119.4 million in 2010 compared to $98.8 million in 2009, reflecting a 21 percent increase. Gross margin for the fourth quarter of 2010 was 50 percent compared to 33 percent in the fourth quarter of 2009, reflecting improved margins in the company’s VPC contracts. Gross…

Continue Reading

ThursdayMar 10, 2011 7:53 am

Energtek Inc. (EGTK.PK) Reports 5 Billion Cubic Feet of Prospective Gas Resources

Energtek Inc. announced that it has completed an evaluation of gas reservoirs in the licensed block in Southern Israel. The evaluation was performed following the successful production test, as reported in December 2010, of the NirAm Gas1 well. Based on the seismic and geophysics data as well as a detailed analysis of the production test's results, the geological team estimated that the recoverable gas resources (contingent resources) of the reservoir at which the NirAm Gas1 was drilled amount to 1.7 BCF (Billion Cubic Feet). Furthermore, the geological team identified three similar natural gas reservoirs in the Nir-Am block. According to…

Continue Reading

WednesdayMar 09, 2011 3:34 pm

Global Health Ventures (GHLV.OB) Takes Viagra Head On

Whether it is comfortable “table talk” or not, there are certain aspects of biotechnology stocks, such as anal fissures or sexually transmitted diseases, that produce incredible amounts of revenue each year for the companies behind therapies that treat the given ailment. Erectile dysfunction may not be the most pleasant of conversations for many people, but the bottom line is that Pfizer has generated a great deal of cash since bringing Viagara to market and that reason alone is enough to catch the attention of the investment community. Vancouver, British Columbia-based Global Health, Inc., a specialty pharmaceutical company with expertise in…

Continue Reading

WednesdayMar 09, 2011 3:22 pm

The True 2 Beauty, Inc. (TRTB) Strategy

One of the best ways to understand the strategy and long term direction of any company is to evaluate its history and the history of the people who are responsible for that long term direction. In the case of True 2 Beauty, the key factor is the company’s founder and CEO, Alex Hbaiu. Hbaiu was a biochemist working with Eli Lily, the 11th largest pharmaceutical company in the world ranked by revenue. It was there that he began to perceive a growing demand in the marketplace for sexual enhancement products that were made from 100% natural ingredients, safe to use…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered